KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
62 hedge funds and large institutions have $1.18B invested in Kinnate Biopharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
18% less capital invested
Capital invested by funds: $1.43B → $1.18B (-$251M)
Holders
62
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$28.1M | |
| 2 | +$14.1M | |
| 3 | +$11.4M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.52M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.71M |
Top Sellers
| 1 | -$9.73M | |
| 2 | -$6.96M | |
| 3 | -$6.66M | |
| 4 |
Millennium Management
New York
|
-$3.57M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.42M |